Research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke

Nowadays, antiplatelet drugs are still the routine medication in the acute phase and in secondary prevention of ischemic stroke. Although the clinical effect of classic antiplatelet drugs, such as aspirin and clopidogrel, has been recognized, some problems still exist, such as clopidogrel resistance...

Full description

Bibliographic Details
Main Authors: Pan LI, Yu-ying ZHOU
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2013-04-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/696
_version_ 1811308465265573888
author Pan LI
Yu-ying ZHOU
author_facet Pan LI
Yu-ying ZHOU
author_sort Pan LI
collection DOAJ
description Nowadays, antiplatelet drugs are still the routine medication in the acute phase and in secondary prevention of ischemic stroke. Although the clinical effect of classic antiplatelet drugs, such as aspirin and clopidogrel, has been recognized, some problems still exist, such as clopidogrel resistance and increased bleeding risk. Therefore, new antiplatelet drugs have been studied and are incorporated into the clinical use currently. Their different pharmacokinetic and pharmacodynamic properties are good additions to the classic antiplatelet therapy, so as to overcome the limitations of the latter. This article will summarize existing clinical evidences and highlight the main features of new antiplatelet drugs, as well as listing some challenges in the use of these therapies. <br />
first_indexed 2024-04-13T09:23:39Z
format Article
id doaj.art-9f2809576ed9423d8c35bad59f1a905a
institution Directory Open Access Journal
issn 1672-6731
language English
last_indexed 2024-04-13T09:23:39Z
publishDate 2013-04-01
publisher Tianjin Huanhu Hospital
record_format Article
series Chinese Journal of Contemporary Neurology and Neurosurgery
spelling doaj.art-9f2809576ed9423d8c35bad59f1a905a2022-12-22T02:52:31ZengTianjin Huanhu HospitalChinese Journal of Contemporary Neurology and Neurosurgery1672-67312013-04-01134273278695Research progress of new antiplatelet drugs in the prevention and treatment for ischemic strokePan LIYu-ying ZHOUNowadays, antiplatelet drugs are still the routine medication in the acute phase and in secondary prevention of ischemic stroke. Although the clinical effect of classic antiplatelet drugs, such as aspirin and clopidogrel, has been recognized, some problems still exist, such as clopidogrel resistance and increased bleeding risk. Therefore, new antiplatelet drugs have been studied and are incorporated into the clinical use currently. Their different pharmacokinetic and pharmacodynamic properties are good additions to the classic antiplatelet therapy, so as to overcome the limitations of the latter. This article will summarize existing clinical evidences and highlight the main features of new antiplatelet drugs, as well as listing some challenges in the use of these therapies. <br />http://www.cjcnn.org/index.php/cjcnn/article/view/696Platelet aggregation inhibitorsBrain ischemiaStrokeReview
spellingShingle Pan LI
Yu-ying ZHOU
Research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke
Chinese Journal of Contemporary Neurology and Neurosurgery
Platelet aggregation inhibitors
Brain ischemia
Stroke
Review
title Research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke
title_full Research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke
title_fullStr Research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke
title_full_unstemmed Research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke
title_short Research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke
title_sort research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke
topic Platelet aggregation inhibitors
Brain ischemia
Stroke
Review
url http://www.cjcnn.org/index.php/cjcnn/article/view/696
work_keys_str_mv AT panli researchprogressofnewantiplateletdrugsinthepreventionandtreatmentforischemicstroke
AT yuyingzhou researchprogressofnewantiplateletdrugsinthepreventionandtreatmentforischemicstroke